✦ LIBER ✦

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1

✍ Scribed by Eiichi Ogawa; Norihiro Furusyo; Masayuki Murata; Hiroaki Ikezaki; Takeshi Ihara; Takeo Hayashi; Kazuhiro Toyoda; Hiroaki Taniai; Kyoko Okada; Mosaburo Kainuma; Jun Hayashi

Book ID: 116652802
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 796 KB
Volume: 57
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.04.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of the IL28B genotype with i

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C

✍ Albert Friedrich Stättermayer; Karoline Rutter; Sandra Beinhardt; Thomas-Matthia 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 636 KB

Treatment of chronic hepatitis C in HIV

Treatment of chronic hepatitis C in HIV infected patients (PTS) with pegylated interferon alpha 2B (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2B

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated

Short treatment (14 weeks) with pegylate

Short treatment (14 weeks) with pegylated interferon alpha-2B and ribavirin for the treatment of hepatitis C genotype 2/3 infection

✍ O. Dalgard; K. Skaug; S. Ritland; B. Myrvang; K. Hellum; K. Bjoro; H. Bell 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 307 KB

IL28B But Not ITPA Polymorphism Is Predi

IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

✍ Kamatani, N.; Sezaki, H.; Chayama, K.; Hayes, C. N.; Abe, H.; Miki, D.; Ochi, H. 📂 Article 📅 2011 🏛 University of Chicago Press 🌐 English ⚖ 454 KB

Impact of early viral kinetics on pegyla

Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C

✍ H. Nomura; Y. Miyagi; H. Tanimoto; H. Ishibashi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB